Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (12) , 1933-1939
- https://doi.org/10.1097/00004872-199917121-00024
Abstract
Both LDL-cholesterol and angiotensin II have been shown to increase the risk for and severity of cardiovascular disease. In hypercholesterolaemia, experimental studies have demonstrated an increased angiotensin type 1 (AT1) receptor expression on vascular smooth muscle cells and an increased vascular responsiveness to vasopressors has been documented in humans. We investigated in a normocholesterolaemic young population whether vascular responsiveness to angiotensin II (Ang II) infusion depends on LDL-cholesterol serum levels in the systemic and renal circulation. Changes in systolic and diastolic blood pressure (ΔBP) to Ang II infusion (0.5 and 3.0 ng/kg per min) were investigated in 103 normocholesterolaemic (LDL-cholesterol 111 mg/dl). Blood pressure (BP) responses to Ang II infusion 3.0 ng/kg per min were enhanced in the group with the highest LDL-cholesterol levels (Δ systolic BP: +12.8 ± 6.7, +13.2 ± 8.6, +17.9 ± 9.6, P P In young male subjects, responsiveness to Ang II is determined by the LDL-cholesterol serum level even in the normal range of LDL-cholesterol, thereby potentially contributing to the cardiovascular risk of LDL- cholesterol even within the so-called normal range.Keywords
This publication has 29 references indexed in Scilit:
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic PatientsCirculation, 1998
- Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential HypertensionCirculation, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The Ib Phase of Ventricular Arrhythmias in Ischemic In Situ Porcine Heart Is Related to Changes in Cell-to-Cell Electrical CouplingCirculation, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Involvement of LDL receptor in the proliferation of vascular smooth muscle cellsAtherosclerosis, 1994
- Novel cellular activities for low density lipoprotein in vascular smooth muscle cells.Hypertension, 1990
- Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.Hypertension, 1989
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971